Welcome to the Pubget Medical Subject Headings (MeSH) browser.
Click on a topic or subtopic below to explore related papers. You'll find the most recent paper about the current MeSH term along with other related papers below.
Cardiovascular Diseases (5)
Articles on Cardiovascular Diseases
-
The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised pl...
Br J Nutr 107(11):1694-706 (2012) PMID 21996130
Animal and human studies suggest that a malleable protein matrix (MPM) from whey decreases plasma lipid concentrations and may positively influence other components of the metabolic syndrome such as glucose metabolism and blood pressure (BP). The primary objective of this double-blin... -
The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised pl...
Br J Nutr 107(11):1694-706 (2012) PMID 21996130
Animal and human studies suggest that a malleable protein matrix (MPM) from whey decreases plasma lipid concentrations and may positively influence other components of the metabolic syndrome such as glucose metabolism and blood pressure (BP). The primary objective of this double-blin... -
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
Diabetes Metab 14(6):523-30 (2012) PMID 22192338
The Sibutramine Cardiovascular OUTcomes trial showed that sibutramine produced greater mean weight loss than placebo but increased cardiovascular morbidity but not mortality. The relationship between 12-month weight loss and subsequent cardiovascular outcomes is explored.... -
Cause-specific mortality in diabetes: recent changes in trend mortality.
Eur J Prev Cardiol 19(3):374-81 (2012) PMID 22991697
Diabetes is one of the most chronic diseases in Western populations. Mortality rates in diabetic patients are higher than in the general population and their prognosis following any cardiovascular event is generally worse. Type 1 diabetic patients' acute complications-related mortali... -
Abstracts of the British Cardiovascular Society Annual Conference. May 28-30, 2012. Manchester, United Kingdom.
Heart (2012) PMID 22629550
-
Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents
Diabetes Metab (2012) PMID 22405266
The two classes of incretin-related therapies, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have become important treatment options for patients with type 2 diabetes. Sitagliptin, saxagliptin, vildagliptin and linagliptin, the a... -
Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents
Diabetes Metab (2012) PMID 22405266
The two classes of incretin-related therapies, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have become important treatment options for patients with type 2 diabetes. Sitagliptin, saxagliptin, vildagliptin and linagliptin, the a... -
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a sy...
Diabetologia 55(4):885-904 (2012) PMID 22278337
vitamin E improved histological disease activity when administered for 2 years, but increased insulin resistance and plasma triacylglycerols. Weight loss is safe, and improves liver histology and cardio-metabolic profile. For patients not responding to lifestyle intervention, piogli... -
[Analysis of causes of death in patients hospitalized in the department of pneumonology].
Pol Merkur Lekarski 32(190):221-4 (2012) PMID 22708277
We retrospectively analyzed data of 188 patients who had died in our Department in 2010. The three leading causes of death in our patients were: respiratory diseases (pneumonia, chronic obstructive pulmonary disease), neoplasmas and cardiovascular diseases (cardiac failure)--35.1, 33... -
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a sy...
Diabetologia 55(4):885-904 (2012) PMID 22278337
vitamin E improved histological disease activity when administered for 2 years, but increased insulin resistance and plasma triacylglycerols. Weight loss is safe, and improves liver histology and cardio-metabolic profile. For patients not responding to lifestyle intervention, piogli...
